ASCENDIS PHARMA A/S
ASNDNASDAQ🏆 #573 by market capEarnings Nov 9 · PostUS Equity
$249.55▲ $3.69 (+1.50%)
🌙 After hours$250.00▲ 0.18%Regular close · extended-hours price shownTrack ASND
Get earnings, price moves & breaking news on Telegram
24h▲ 1.5%
7d▲ 2.7%
14d▲ 10.1%
30d▲ 9.3%
ytd▲ 17.1%
1y▲ 21.2%
🏦Market Cap
$16.57B
Mid Cap
📈Revenue Growth (YoY)
113.3%
High Growth
📊Gross Margin
91.3%
High
💵FCF Margin
33.5%
Strong
⚖️P/S Ratio
13.2x
Elevated
Otter Score
68
Fair
Earnings
Q3 · 2026Reported 2026-08-13Earnings Per Share
Actual
3.29
Expected
1.71
beat
+92.40%
YoY +453.80%
Revenue
Actual
$387.48M
Expected
$376.75M
beat
+2.80%
YoY +108.20%
Consensus estimates
Recent quarters
Q3 2026
3.29
beat
Q2 2026
0.32
beat
Q1 2026
-0.64
miss
Q4 2025
-1.17
miss